The effect on ephedrine prodrugs on locomotor activity in rats

General Pharmacology

Volumn 27, Issue 1, 1996, Pages 109-111

  Walker, Richard B ^a   Fitz, Lawrence D ^a   Williams, Lance M ^a   McDaniel, Yolanda M ^a  

^a UNIVERSITY OF ARKANSAS AT PINE BLUFF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; BUTYRALDEHYDE; EPHEDRINE; FORMALDEHYDE; ISOBUTYRALDEHYDE; OXAZOLIDINE DERIVATIVE; PRODRUG; PROPIONALDEHYDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG STRUCTURE; DRUG SYNTHESIS; HALF LIFE TIME; HYDROLYSIS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT;

EID: 0029917509     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00127-1     Document Type: Article

References (13)

1. Agami C., Meynier F., Berlan J., Besace Y. and Brochard L. (1986) Chiral 3-substituted aldehydes; determination of absolute configurations and enantiomeric excesses by NMR analysis of derived oxazolidines. J. Org. Chem. 51, 73-75.
2. Beckett A. H., Jones G. R. and Hollingsbee D. A. (1978) Degradation of (-) ephedrine in solution during extraction with diethyl ether. J. Pharm. Pharmac. 30, 15-19.
3. Bundgaard H. and Johansen M. (1983) Pro-drugs as drug delivery systems XX. Oxazolidines as potential pro-drug types for beta-aminoalcohols, aldehydes or ketones. Int. J. Pharmac. 10, 165-175.
4. Chien D. S. and Schoenwald R. D. (1986) Improving the ocular absorption of phenylephrine. Biopharmac. Drug Disposal 7, 453-462.
5. Chien D. S. and Schoenwald R. D. (1990) Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. Pharmac. Res. 7, 476-483.
6. Gilman A. G., Goodman L. S., Rall T. W. and Murad F. (1985) In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th ed., pp. 169-170. MacMillan Publishing Company, New York.
7. Johansen M. and Bundgaard H. (1983) Pro-drugs as drug delivery systems XXV: hydrolysis of oxazolidines-a potential new pro-drug type. J. Pharmac. Sci. 72, 1294-1298.
8. Walker R. B., Wood D. M. and Akmal M. M. (1990) Hyperthermic and anorectic effects of oxazolidines derived from 1-ephedrine in rats. Life Sci. 47, 595-600.
9. Walker, R. B., Wood D. M., Akmal M. M. and Sharks E. (1992) Effects of oxazolidines derived from (-) ephedrine in the rat. Gen. Pharmac. 23, 729-732.
10. Walker R. B., Fitz L. D., Williams L. M., Linton H. Jr. and Smith C. C. (1992) The effect of ephedrine isomers and their oxazolidines on locomotor activity in rats. Gen. Pharmac. 24, 669-673.
11. Yamahara J., Kimata M., Sawada T. and Fujimura H. (1985) Possible involvement of beta-2 adrenoreceptors in hyperthermic effect of 1-ephedrine in rats. J. Pharmaco-biodyn. 8, 591-596.
12. Young-Harvey J. A., Rae I. D. and Pitman I. (1986) Oxazolidines: pro-drugs for the delivery of beta-aminoalcohols through human skin from aqueous solutions. Int. J. Pharmac. 18, 559-561.
13. Zarrindast M. R. (1981) Dopamine-like properties of ephedrine in rat brain. Br. J. Pharmac. 74, 119-122.